你好,欢迎访问上海交通大学附属第一人民医院公济文库!
所在位置: 首页 - 科室团队导航 - 肿瘤临床医学中心
相关导航
按语种分组
  • 任何
  • 413 中文
  • 372 外文
年代
  • 任何
  • 49 2021
  • 90 2020
  • 60 2019
  • 63 2018
  • 58 2017
  • 45 2016
  • 35 2015
  • 34 2014
  • 18 2013
  • 22 2012
  • 34 2011
  • 18 2010
  • 214 2000-2009
  • 41 1990-1999
按类型分组
  • 任何
  • 366 中文期刊
  • 362 外文期刊
  • 27 中文会议论文
  • 18 中文专利
  • 9 外文专利
  • 更多
按重要期刊分组
  • 任何
  • 315 SCI科学引文索引(美)
  • 261 国内统计源期刊
  • 250 SCIE
  • 213 CSCD中国科学引文库
  • 181 CA化学文摘(美)
  • 更多
按来源刊物分组
  • 任何
  • 23 中国癌症杂志
  • 17 肿瘤
  • 16 中华眼科杂志
  • 13 现代生物医学进展
  • 12 Annals of Onc
  • 更多
科室简介: 成果数量:785

上海交通大学附属第一人民医院肿瘤科是上海市三甲综合医院中最早设立的肿瘤专科,是医院“十二五”期间重点发展的学科之一。2009年,医院整合肿瘤相关学科资源,成立了肿瘤中心,学科带头人黄倩教授,中心主任王理伟教授,肿瘤中心副主任王红霞(兼肿瘤科副主任[主持,南])、刘勇副主任医师,北部执行主任李琦主任医... [详细]

本科室知名学者:
本科室科研趋势: 发文数量 期刊收录
条数据
导出

作者: Chen Dong, Wenzhi Tu, Mingyuan He, Jiamei Fu, Alisa Kobayashi, Teruaki Konishi, Chunlin Shao (Affiliations 1 Institute of Radiation Medicine, Fudan University, Shanghai 200032, China. 2 The Comprehensive Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China. 3 Department of Accelerator and Medical Physics, National Institute of Radiological Sciences. 4 Department of Single Cell Radiation Biology Group, Institute for Quantum Life Science, National Institutes for Quantum and Radiological Science and Technology, Inage, Chiba 263-8555, Japan.)

出处: Radiation research 2020 Vol.193 No.1 P63-72

摘要: It is well known that mitochondria and the endoplasmic reticulum (ER) play important roles in radiation response, but their functions in radiation-ind ...

作者: Minghui Zhao, Yiwei Wang, Yucui Zhao, Sijia He, Ruyi Zhao, Yanwei Song, Jin Cheng, Yanping Gong, Jianzhu Xie, Yulan Wang, Binjie Hu, Ling Tian, Qian Huang (Affiliations 1 Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China. 2 Shanghai Key Laboratory for Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China. 3 Department of Central Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.)

出处: Aging 2020 Vol.12

关键词: DNA damage response;caspase-3;non-small cell lung cancer;radiotherapy;tumor repopulation.

摘要: Radiotherapy is an effective treatment for non-small cell lung cancer (NSCLC). However, irradiated, dying tumor cells generate potent growth stimulato ...

作者: Yanli Li, Rui Yang, Limo Chen, Sufang Wu (Affiliations 1 Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China. 2 Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.)

出处: Future oncology (London, England) 2020

关键词: CD38;biomarker;cancer immunotherapy;immune checkpoint therapy;immunomodulation;tumor microenvironment.

摘要: CD38 is a transmembrane glycoprotein that is widely expressed in a variety of human tissues and cells, especially those in the immune system. CD38 pro ...

作者: Xuguang Yang, Yun Lu, Junjie Hang, Junfeng Zhang, Tiening Zhang, Yanmiao Huo, Jun Liu, Songtao Lai, Dawei Luo, Liwei Wang, Rong Hua, Yuli Lin (Affiliations 1 The Comprehensive Cancer Center, Department of Oncology, State Key Laboratory for Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University. 2 Longhua Hospital Shanghai University of Traditional Chinese Medicine. 3 Department of Oncology, Changzhou No.2 People\'s Hospital, Nanjing Medical University. 4 Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University. 5 radiation department, Shanghai General Hospital, Shanghai Jiaotong University. 6 Oncology Center, Shanghai General Hospital, Shanghai Jiaotong University. 7 Department of Radiation Oncology, Shanghai Cancer Center, Shanghai Medical College, Fudan University. 8 Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University. 9 Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University. 10 Department of Immunology, School of Basic Medical Sciences, Fudan University yulilin@fudan.edu.cn.)

出处: Cancer immunology research 2020

摘要: The mechanisms responsible for radioresistance in pancreatic cancer have yet to be elucidated and the suppressive tumor immune microenvironment must b ...

作者: Zhong Wan, Tingyu Liu, Liang Wang, Rong Wang, Hai Zhang (Affiliations 1 Department of Pharmacy, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China. 2 Urologic Medical Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China. 3 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China. 4 Department of Pharmacy, Shanghai 9th People\'s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201999, China.)

出处: Aging 2020 Vol.12 No.18 P18192-18208

关键词: MAPK14;hepatocellular carcinoma;miR-216a-3p;sorafenib resistance.

摘要: We investigated MAPK14-dependent resistance to sorafenib in hepatocellular carcinoma (HCC). Bioinformatics analysis and dual luciferase reporter assay ...

作者: Liu, Y.;Lu, L.-L.;Wen, D.;Liu, D.-L.;Dong, L.-L.;Gao, D.-M.;Bian, X.-Y.;Zhou, J.;Fan, J.;Wu, W.-Z. (a Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, 180 Fenglin Road, Shanghai, 200032, China; b Department of Oral Maxillofacial-Head and Neck Oncology, Shanghai Ninth People\'s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; c Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; d Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, 200080, China; e Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China)

出处: Journal of Hematology and Oncology 2020 Vol.13 No.1

摘要: The original article \'(1)\' contains an error in Fig. 3c and Fig. 3g whereby the image of group WT and NC in HCCLM3 cell lines were repeated. The cor ...

作者: Tao Wang;Quan Zhou;Han Zeng;Hongyu Zhang;Zhaopei Liu;Jialiang Shao;Zewei Wang;Ying Xiong;Jiajun Wang;Qi Bai;Yu Xia;Yiwei Wang;Li Liu;Yu Zhu;Le Xu;Bo Dai;Jianming Guo;Yuan Chang;Xiang Wang;Jiejie Xu (Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China. Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China. Department of Urology, Shanghai Ninth People\'s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. changyuan0802@163.com. Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China. drseanwang@163.com. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China. jjxufdu@fudan.edu.cn.)

出处: Cancer immunology, immunotherapy 2020

关键词: CCR8+Treg;Immune evasion;Muscle-invasive bladder cancer;Prognosis;Therapeutic target

摘要: Regulatory T cells (Tregs) play a major role in the development of an immunosuppressive tumor microenvironment. Systemic Treg depletion is not favored ...

作者: Fan, Xing-Wen (AUTHOR);Yang, Yu (AUTHOR);Wang, Hong-Bing (AUTHOR);Xu, Yin (AUTHOR);Kang, Mei (AUTHOR);Xie, Li-Yi (AUTHOR);Li, Ling (AUTHOR);Fang, Wen-Tao (AUTHOR);Zhao, Kuai-Le (AUTHOR);Chen, Hai-Quan (AUTHOR);Xiang, Jia-Qing (AUTHOR);Ung, Yee C. (AUTHOR);Wong, C. Shun (AUTHOR);Jiang, Guo-Liang (AUTHOR);Wu, Kai-Liang (AUTHOR)( wukailiang@aliyun.com) (1 Department of Radiation Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China 2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China 3 Clinical Research Center, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China 4 Department of Thoracic Surgery, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, China 5 Department of Thoracic Surgery, Shanghai Cancer Center, Fudan University, Shanghai, China 6 Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada 7 Department of Radiation Oncology, Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai Proton and Heavy Ion Center, Shanghai, China)

出处: International Journal of Radiation Oncology, Biology, Physics 2020 Vol.107 No.1 P98-105

关键词: etoposide/cisplatin;intensity-modulated radiotherapy;thymic carcinoma;thymoma

摘要: Purpose: This prospective phase 2 study evaluated the efficacy and safety of intensity modulated radiation therapy plus etoposide/cisplatin (EP) for p ...

作者: Baoying Hu;Zewei Wang;Han Zeng;Yangyang Qi;Yifan Chen;Tao Wang;Jiajun Wang;Yuan Chang;Qi Bai;Yu Xia;Yiwei Wang;Li Liu;Yu Zhu;Bo Dai;Jianming Guo;Le Xu;Weijuan Zhang;Jiejie Xu (Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University. Department of Urology, Zhongshan Hospital of Fudan University. Department of Immunology, Shanghai Medical College of Fudan University. Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University. Department of Urology, Zhongshan Hospital, Fudan University. Department of Urology, Fudan University Shanghai Cancer Center. Department of Urology, Shanghai Ninth People\'s Hospital, Shanghai Jiao Tong University School of Medicine. Urology, Fudan University Shanghai Cancer Center. Department of Urology, Zhongshan Hospital Fudan University. Department of Urology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University jjxufdu@fudan.edu.cn.)

出处: Cancer research 2020

摘要: Tumor-associated macrophages (TAMs) play an indispensable role in the modulation of the cancer immune microenvironment. Despite the fact that TAMs may ...

作者: Runzhi Huang, Jiaqi Zhang, Mingxiao Li, Penghui Yan, Huabin Yin, Suna Zhai, Xiaolong Zhu, Peng Hu, Jiaxin Zhang, Ling Huang, Man Li, Zehui Sun, Tong Meng, Daoke Yang, Zongqiang Huang (Affiliations 1 Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, Zhengzhou, China. 2 Division of Spine, Department of Orthopedics, Tongji Hospital Affiliated to Tongji University School of Medicine, 389 Xincun Road, Shanghai, China. 3 Tongji University School of Medicine, 1239 Siping Road, Shanghai 200092, China. 4 Department of Orthopedics, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, 100 Haining Road, Shanghai, China. 5 Department of Radiotherpy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. 6 Tongji University Cancer Center, Shanghai Tenth People\'s Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, China.)

出处: PPAR research 2020 Vol.2020 P6527564

摘要: Peroxisome proliferator-activated receptors (PPARs) are members of nuclear transcription factors. The functions of the PPAR family (PPARA, PPARD, and ...

肿瘤临床医学中心简介

上海交通大学附属第一人民医院肿瘤科是上海市三甲综合医院中最早设立的肿瘤专科,是医院“十二五”期间重点发展的学科之一。2009年,医院整合肿瘤相关学科资源,成立了肿瘤中心,学科带头人黄倩教授,中心主任王理伟教授,肿瘤中心副主任王红霞(兼肿瘤科副主任[主持,南])、刘勇副主任医师,北部执行主任李琦主任医师。目前,肿瘤中心下设肿瘤内科、肿瘤放疗科、肿瘤介入科、肿瘤基因诊断及生物治疗科。目前肿瘤中心核定床位数185张,科室现有医技人员共50人,其中医生36人,正高级职称7人,副高级职称9人,中级职称18人,具有博士学历11人,硕士学历18人,博士研究生导师3人,硕士研究生导师5人;5人曾在国外进修学习,2人目前正在国外学习。肿瘤中心现为中国抗癌协会临床肿瘤学会(CSCO)执行委员会单位,CSCO胰腺癌专家委员会主任委员单位、CSCO抗肿瘤药物安全管理委员会委员单位、上海市抗癌协会理事单位、上海市医学会肿瘤专科委员会副主任委员单位、上海市肿瘤放射治疗专业委员会委员单位、上海市肿瘤化疗质控中心专家委员单位、上海市肿瘤放疗质控专家委员会单位。
2013年,经全院肿瘤相关专科共同努力,肿瘤中心入选国家临床重点专科建设项目,建设经费500万元。近3年,获得国家级课题(含国家自然科学基金重大研究计划、国家“973”“863”计划、重大国际合作)17项(仅2015年获得国家自然科学基金9项)、市级课题10项,各类科研经费2500余万元。在《Nature Medicine》、《Gastroenterology》等杂志发表高质量SCI论文。在胰腺癌的基础研究与临床诊治方面在上海市乃至全国颇具影响,主持编写了《胰腺癌患者健康教育手册》、中国首部《胰腺癌综合诊治中国专家共识》,为上海市胰腺疾病重点实验室及上海交通大学胰腺癌诊治中心。在人才培养方面,1人入选国家杰出青年基金计划、1人入选“百千万人才工程”国家级人选、1人入选上海市医学领军人才、1人入选上海市优秀学科带头人计划、3人入选上海市“浦江人才计划”。
2013年成立了肿瘤诊治中心以来,肿瘤学科得到迅猛发展。中心集肿瘤预防、诊断、综合治疗和康复为一体,能开展各项专科项目并形成如下医疗特色:
1.肿瘤个体化化疗、靶向治疗、免疫治疗:根据每位患者独特的基因表达情况,制定个体化的化疗方案,联合靶向治疗,极大提高了结直肠癌、肺癌、乳腺癌、胃癌等治疗效果。
2.精准放疗:目前拥有直线加速器3台,其中包括最先进的VARIAN-RapidArc治疗系统,实现了对实体肿瘤的精准放疗。现已开展三维适形放射治疗、调强适形放射治疗、图像引导下的三维适形调强放疗、同步放化疗、PET-CT引导下放疗、立体定向放射治疗等。
3.肿瘤微创治疗:在上海市开展了首例纳米刀治疗局部晚期胰腺癌,还包括高强度超声聚焦治疗系统(HIFU刀)、射频/微波肿瘤消融治疗系统、高频热疗系统、放射性粒子组织间植入治疗系统、氩氦刀低温冷冻肿瘤治疗系统、血管介入等技术,适用于治疗肝癌、肺癌等实体肿瘤。
4.肿瘤分子诊断:包括免疫功能检测、EGFR、K-ras、BRAF等基因突变检测,Her-2基因扩增检测,循环血肿瘤细胞检测等,为肿瘤患者个体化治疗与靶向治疗选择,以及预后判断,提供了更准确的方法。
5.开设肿瘤多学科联合诊治:多学科、多专家共同参与,为患者制定个体化、综合治疗方案,实现对每位肿瘤患者的全称管理,为肿瘤患者提供最科学的诊断治疗技术和最优质的一站式服务。
6.肿瘤生物治疗:全国率先开展生物免疫治疗与现有传统治疗手段(化疗、放疗)综合治疗实体肿瘤(胰腺癌、乳腺癌等),开展单病种肿瘤生物免疫治疗临床研究多项,通过规范病例入组,规范细胞制备与使用,规范疗效评价,并建立相应的疗效评估体系及规范。
7.新药临床研究:在医院药物临床研究机构的监督下,牵头、参与国际多中心临床研究,为结直肠癌、胰腺癌、乳腺癌、胃癌、肺癌等患者提供最新的药物治疗。
8.中心静脉置管及护理: 1999年我科成功置入上海市第一根PICC导管,开创了护士进 行中心静脉置管的新篇章。2006年引入PORT技术,2007年在全国率先开展非超声引导下塞丁格(MST)穿刺技术,2009年引入B超引导下置管技术,新技术的引进提高了PICC置管成功率,解决了临床实际问题。
目前,肿瘤中心的主要研究方向有:胰腺癌的临床及基础研究、胰腺癌炎-癌转化的基础研究、乳腺癌的基础与临床转化研究、三阴性乳腺癌的精准与免疫治疗研究、肿瘤放疗后再增殖研究、肺癌基础研究、转录因子对肝癌发生发展影响的机制研究、基因多态性与化疗敏感性的临床研究、血药浓度检测与化疗敏感性的临床研究等。"